<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fluorescence in situ hybridization (FISH) is being used increasingly in cytogenetic diagnosis of <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>However, the utility of FISH in this role has not been well-defined </plain></SENT>
<SENT sid="2" pm="."><plain>A total of 249 de novo <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients were submitted to karyotyping and FISH analysis for -5/del(5)(q31), -7/del(7)(q31), +8, -17/i(17)(q10), del(20)(q12), and -Y </plain></SENT>
<SENT sid="3" pm="."><plain>Of the 234 patients with available karyotypic data, 143 cases (60.9%) demonstrated <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype and 91 cases (39.1%) showed abnormal karyotype </plain></SENT>
<SENT sid="4" pm="."><plain>FISH confirmed R-banding findings in 96.6% (226/234) of samples with successful karyotyping and detected cytogenetic abnormalities in 46.7% (7/15) of cases with karyotype failure </plain></SENT>
<SENT sid="5" pm="."><plain>Of the 3.4% (8/234) patients showing discrepancies between FISH and R-banding, FISH revealed cytogenetic abnormalities in four patients with <z:mpath ids='MPATH_458'>normal</z:mpath> karyotypes and four patients with complex karyotypes </plain></SENT>
<SENT sid="6" pm="."><plain>These results highlight FISH analysis has limited value in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> cases with successful karyotyping and is only informative in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> cases with karyotype failure </plain></SENT>
</text></document>